Operating within the conceptual framework of radiation turning the tumor into an in situ vaccine [33], CPI and MerTK inhibition can be thought of as immune stimulators, each providing independent, synergistic stimulation to the immune system that multiplies its activation following this radiological “vaccination”. The gene discussed is MERTK; the disease is neoplasm.